Literature DB >> 8348739

Elevated serum levels of IL-8 in patients with HIV infection.

T Matsumoto1, T Miike, R P Nelson, W L Trudeau, R F Lockey, J Yodoi.   

Abstract

Serum levels of IL-8 were determined in HIV-infected individuals and the results were compared with those for HIV- controls. The IL-8 levels were measured by an ELISA with a MoAb and a polyclonal antibody to recombinant IL-8. The means and 95% confidence intervals of IL-8 in sera of 36 HIV-infected individuals and 32 matched controls were 275 and 216-349 pg/ml, and 8 and 4-14 pg/ml, respectively, showing a 34-fold increase in IL-8 in the circulation of HIV-infected individuals. This increase does not appear to be related to the disease state, infection or systemic medical agents. This finding suggests the possible involvement of IL-8 in the pathogenesis of HIV-induced disease.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8348739      PMCID： PMC1554855          DOI： 10.1111/j.1365-2249.1993.tb07957.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  17 in total

1.  Mononuclear cells from HIV-infected patients produce factors which enhance functional activity of polymorphonuclear neutrophils from healthy subjects.

Authors:  D I Gabrilovich; G K Shepeleva; L V Serebrovskaya; L A Avdeeva; Z K Suvorova; I M Rosly; V K Oganezov; M Z Saidov; A V Panyutich; V V Pokrovsky
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing.

Authors:  P J Stiff; A R Koester; M K Weidner; K Dvorak; R I Fisher
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

3.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor.

Authors:  E Roilides; S Mertins; J Eddy; T J Walsh; P A Pizzo; M Rubin
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

5.  IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha.

Authors:  N Sheron; R Williams
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1).

Authors:  J M Molina; R Schindler; R Ferriani; M Sakaguchi; E Vannier; C A Dinarello; J E Groopman
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

7.  IL-8 in septic shock, endotoxemia, and after IL-1 administration.

Authors:  K J Van Zee; L E DeForge; E Fischer; M A Marano; J S Kenney; D G Remick; S F Lowry; L L Moldawer
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

8.  Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV-infected subjects.

Authors:  F Capsoni; F Minonzio; A M Ongari; G Colombo; G P Rizzardi; P Bonara; A D'Arminio-Monforte; C Zanussi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

9.  Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood.

Authors:  L E DeForge; D G Remick
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

10.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422
View more
  37 in total

1.  Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Authors:  Brian R Lane; Jianguo Liu; Paul J Bock; Dominique Schols; Michael J Coffey; Robert M Strieter; Peter J Polverini; David M Markovitz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals.

Authors:  S Meddows-Taylor; D J Martin; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Transcriptional and post-transcriptional regulation of interleukin-8.

Authors:  L H Villarete; D G Remick
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.

Authors:  P Roux; C Alfieri; M Hrimech; E A Cohen; J E Tanner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 5.  Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.

Authors:  Sharof Tugizov
Journal:  Tissue Barriers       Date:  2016-03-03

6.  Native X-DING-CD4 protein secreted by HIV-1 resistant CD4+ T cells blocks activity of IL-8 promoter in human endothelial cells infected with enteric bacteria.

Authors:  Anna Ivanova; Rasheda Y Shilpi; Rakhee Sachdeva; Guanhua Li; Malgorzata Simm
Journal:  Innate Immun       Date:  2011-10-26       Impact factor: 2.680

7.  Serum levels of interleukin-8 in patients with Behcet's disease.

Authors:  K Ozoran; O Aydintuğ; G Tokgöz; N Düzgün; H Tutkak; A Gürler
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

8.  Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.

Authors:  M Bradley Drummond; Gregory D Kirk; Erin P Ricketts; Meredith C McCormack; J Christian Hague; John F McDyer; Shruti H Mehta; Eric A Engels; Robert A Wise; Christian A Merlo
Journal:  BMC Pulm Med       Date:  2010-05-11       Impact factor: 3.317

9.  Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein.

Authors:  R Mahieux; P F Lambert; E Agbottah; M A Halanski; L Deng; F Kashanchi; J N Brady
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

Authors:  Teresa G D'Aversa; Karl O A Yu; Joan W Berman
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.